மைக்கேல் டிெக்மன்ன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மைக்கேல் டிெக்மன்ன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மைக்கேல் டிெக்மன்ன் Today - Breaking & Trending Today

Deals of the week May 10 to May 14 – a GrowthBusiness roundup


Deals of the week May 10 to May 14 – a GrowthBusiness roundup
14 May 2021
Growth Business roundup of Deals of the Week, May 10 to May 14, listing seed funding, venture capital and crowdfunding deals of note
Huma signs off £92m in Series C funding
Huma, the digital health platform, has closed another $130m (£92.3m) in Series C funding led by Leaps by Bayer and Munich-based Hitachi Ventures. The investment arms of Bayer, Hitachi, Samsung, Sony Innovation Fund by IGV, Unilever and the PE fund HAT all became investors, as did former Softbank president Nikesh Arora and Allianz chairman Michael Diekmann. Huma, whose clients include the NHS, was named Europe’s fastest-growing healthcare company by the ....

United Kingdom , Melissa Snover , Michael Diekmann , Nikesh Arora , National Grid Partners , Paladin Capital Group , Sony Innovation Fund , Cibus Fund , Munich Based Hitachi , Felix Capital , Allegiscyber Capital , Evolution Equity Partners , Notion Capital , Cisco Investments , National Grid , Apater Capital , Remedy Health , ஒன்றுபட்டது கிஂக்டம் , மெலிசா ஸ்னோவர் , மைக்கேல் டிெக்மன்ன் , நிகேஷ் அரோரா , தேசிய கட்டம் கூட்டாளர்கள் , ப்யாலடிந் மூலதனம் குழு , சோனி கண்டுபிடிப்பு நிதி , சாப்ட் பேங்க் , ஃபெலிக்ஸ் மூலதனம் ,

Huma raises $130 million financing to scale its digital health platform for better care and research


LONDON and NEW YORK
 , May 12, 2021 /PRNewswire/  Huma Therapeutics Limited today announces the completion of its latest funding round with financing of approximately $130 million. The investment will scale Huma s modular platform which can power digital hospitals at home nationally, and support the pharmaceutical and research industries to run the largest ever decentralized clinical trials. Huma s platform combines predictive algorithms, digital biomarkers and real-world data to advance proactive care and research.
Leaps by Bayer and Hitachi Ventures led the Series C funding round, which also saw new strategic and financial investors become shareholders. Samsung Next, Sony Innovation Fund by IGV , Unilever Ventures and HAT Technology & Innovation Fund by HAT, as well as individuals Nikesh Arora (former president of SoftBank) and Michael Diekmann (Chairman of Allianz) are also new shareholders. ....

United Kingdom , City Of , Jonathan Machado , Dan Vahdat , Alan Milburn , Keiji Kojima , Michael Diekmann , Ignazio Castiglioni , Juergen Eckhardt , Gen Tsuchikawa , Claudia Suessmuth Dyckerhoff , Nikesh Arora , Huma Therapeutics , World Economic Forum Global Innovators Community , Innovation Growth Ventures Co Ltd , Daiwa Capital Holdings , Prudential Regulation Authority , United Kingdom Health , University Of Cambridge , Goldman Sachs International , Stanford University Center , Technology Innovation Fund , Sony Innovation Fund , Financial Conduct Authority , Johns Hopkins Bloomberg School Of Public Health , Formative Research ,

Huma, which uses AI and biomarkers to monitor patients and for medical research, raises $130M – TechCrunch


Huma, which uses AI and biomarkers to monitor patients and for medical research, raises $130M
While much of the world eagerly watches to see if the vaccination rollout helps curb and eventually stamp out Covid-19, one of the companies that has been helping to manage the spread of the virus is announcing a big round of funding on the heels for strong demand for its technology.
Huma, which combines data from biomarkers with predictive algorithms both to help monitor patients, and uses the same technology to help researchers and pharmaceutical companies run clinical trials, has closed an equity round of $130 million, a Series C that the company can extend to $200 million by way of a $70 million debt line if it chooses. ....

United Kingdom , City Of , Juergen Eckhardt , Dan Vahdat , Keiji Kojima , Michael Diekmann , Nikesh Arora , Sony Innovation Fund , Technology Innovation Fund , London Based Huma , Hitachi Ventures , Samsung Next , Unilever Ventures , Innovation Fund , Cambridge Fenland , Smart Life , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , ஜூர்கன் எக்கர்டத் , டான் வஹதத் , கேஜி கோஜிமா , மைக்கேல் டிெக்மன்ன் , நிகேஷ் அரோரா , சோனி கண்டுபிடிப்பு நிதி , தொழில்நுட்பம் கண்டுபிடிப்பு நிதி , சாப்ட் பேங்க் ,

Huma raises $130 million to finance its digital health platform – PCR


Huma raises $130 million to finance its digital health platform
5 hours ago
Huma Therapeutics Limited thas raised approximately $130 million to scale its modular platform which can power digital ‘hospitals at home’ nationally, and support the pharmaceutical and research industries to run the largest ever decentralised clinical trials. Huma’s platform combines predictive algorithms, digital biomarkers and real-world data to advance proactive care and research.
Leaps by Bayer and Hitachi Ventures led the Series C funding round, which also saw new strategic and financial investors become shareholders. Samsung Next, Sony Innovation Fund by IGV, Unilever Ventures and HAT Technology & Innovation Fund by HAT, as well as individuals Nikesh Arora (former president of SoftBank) and Michael Diekmann (Chairman of Allianz) are also new shareholders. ....

United Kingdom , Jonathan Machado , Dan Vahdat , Alan Milburn , Keiji Kojima , Michael Diekmann , Gen Tsuchikawa , Claudia Suessmuth Dyckerhoff , Nikesh Arora , Huma Therapeutics , Sony Innovation Fund , Technology Innovation Fund , United Kingdom Health , Goldman Sachs International , Huma Therapeutics Limited , Hitachi Ventures , Unilever Ventures , Innovation Fund , Sachs International , Middle East , United Kingdom Health Secretary , Huma Board Director , Executive Vice President , Smart Life , Senior Investment Director , Samsung Next ,